These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28858089)

  • 1. Adherence, tolerability, and outcome after 36 months of isoniazid-preventive therapy in 2 rural clinics of Swaziland: A prospective observational feasibility study.
    Mueller Y; Mpala Q; Kerschberger B; Rusch B; Mchunu G; Mazibuko S; Bonnet M
    Medicine (Baltimore); 2017 Sep; 96(35):e7740. PubMed ID: 28858089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation and Operational Research: Feasibility of Using Tuberculin Skin Test Screening for Initiation of 36-Month Isoniazid Preventive Therapy in HIV-Infected Patients in Resource-Constrained Settings.
    Huerga H; Mueller Y; Ferlazzo G; Mpala Q; Bevilacqua P; Vasquez B; Noël Mekiedje C; Ouattara A; Mchunu G; Weyenga HO; Varaine F; Bonnet M
    J Acquir Immune Defic Syndr; 2016 Apr; 71(4):e89-95. PubMed ID: 26910386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania.
    Hunter OF; Kyesi F; Ahluwalia AK; Daffé ZN; Munseri P; von Reyn CF; Adams LV
    BMC Infect Dis; 2020 Oct; 20(1):738. PubMed ID: 33028260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The social implications of participant choice on adherence to Isonaizid Preventive Therapy (IPT): A follow-up study to high completion rates in Eswatini.
    Grande SW; Adams LV; Maseko TSB; Talbot EA; deGijsel D; Mikal J; Simelane ZZ; Achili A; Mkhontfo M; Haumba SM
    PLoS One; 2020; 15(5):e0232841. PubMed ID: 32469990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.
    Sensalire S; Karungi Karamagi Nkolo E; Nabwire J; Lawino A; Kiragga D; Muhire M; Kadama H; Katureebe C; Namuwenge P; Musinguzi J; Calnan J; Seyoum D
    AIDS Res Ther; 2020 May; 17(1):28. PubMed ID: 32460788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study.
    Durovni B; Cavalcante SC; Saraceni V; Vellozo V; Israel G; King BS; Cohn S; Efron A; Pacheco AG; Moulton LH; Chaisson RE; Golub JE
    AIDS; 2010 Nov; 24 Suppl 5(Suppl 5):S49-56. PubMed ID: 21079428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contact evaluation and isoniazid preventive therapy among close and household contacts of tuberculosis patients in Lima, Peru: an analysis of routine data.
    Otero L; Battaglioli T; Ríos J; De la Torre Z; Trocones N; Ordoñez C; Seas C; Van der Stuyft P
    Trop Med Int Health; 2020 Mar; 25(3):346-356. PubMed ID: 31758837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High completion rates of isoniazid preventive therapy among persons living with HIV in Swaziland.
    Adams LV; Mahlalela N; Talbot EA; Pasipamire M; Ginindza S; Calnan M; Haumba S
    Int J Tuberc Lung Dis; 2017 Oct; 21(10):1127-1132. PubMed ID: 28911356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid preventive therapy and 4-year incidence of pulmonary tuberculosis among HIV-infected Thai patients.
    Khawcharoenporn T; Apisarnthanarak A; Manosuthi W; Sungkanuparph S; Mundy LM
    Int J Tuberc Lung Dis; 2012; 16(3):336-41. PubMed ID: 22230143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of isoniazid preventive therapy in children aged under 5 years exposed to tuberculosis in Benin.
    Adjobimey M; Masserey E; Adjonou C; Gbénagnon G; Schwoebel V; Anagonou S; Zellweger JP
    Int J Tuberc Lung Dis; 2016 Aug; 20(8):1055-9. PubMed ID: 27393539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to isoniazid preventive therapy in children exposed to tuberculosis: a prospective study from Guinea-Bissau.
    Gomes VF; Wejse C; Oliveira I; Andersen A; Vieira FJ; Carlos LJ; Vieira CS; Aaby P; Gustafson P
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1637-43. PubMed ID: 22118171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data.
    Karanja M; Kingwara L; Owiti P; Kirui E; Ngari F; Kiplimo R; Maina M; Masini E; Onyango E; Ngugi C
    PLoS One; 2020; 15(12):e0234588. PubMed ID: 33264300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study.
    Ayele HT; van Mourik MS; Bonten MJ
    BMC Infect Dis; 2015 Aug; 15():334. PubMed ID: 26269094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.
    Kabali C; von Reyn CF; Brooks DR; Waddell R; Mtei L; Bakari M; Matee M; Pallangyo K; Arbeit RD; Horsburgh CR
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1515-21, i. PubMed ID: 22008766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines of tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study. GISTA (Gruppo Italiano di Studio Tubercolosi e AIDS).
    Antonucci G; Girardi E; Raviglione M; Vanacore P; Angarano G; Chirianni A; Pagano G; Suter F; Lauria FN; Ippolito G
    Eur Respir J; 2001 Aug; 18(2):369-75. PubMed ID: 11529298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability and adherence to Isoniazid preventive therapy in HIV-infected patients clinically screened for latent tuberculosis in Dar es Salaam, Tanzania.
    Shayo GA; Moshiro C; Aboud S; Bakari M; Mugusi FM
    BMC Infect Dis; 2015 Aug; 15():368. PubMed ID: 26306511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to isoniazid preventive therapy among child contacts in Rwanda: A mixed-methods study.
    Birungi FM; Graham SM; Uwimana J; Musabimana A; van Wyk B
    PLoS One; 2019; 14(2):e0211934. PubMed ID: 30742660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors Associated with Absence of Active Pulmonary Tuberculosis in HIV Patients with Latent Tuberculosis, Beyond Isoniazid Preventive Therapy.
    Yuniati SK; Kusmiati T
    Int J Mycobacteriol; 2024 Jul; 13(3):293-298. PubMed ID: 39277892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mixed-methods evaluation of adherence to preventive treatment among child tuberculosis contacts in Indonesia.
    Triasih R; Padmawati RS; Duke T; Robertson C; Sawyer SM; Graham SM
    Int J Tuberc Lung Dis; 2016 Aug; 20(8):1078-83. PubMed ID: 27393543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementing isoniazid preventive therapy in a tuberculosis treatment-experienced cohort on ART.
    Maharaj B; Gengiah TN; Yende-Zuma N; Gengiah S; Naidoo A; Naidoo K
    Int J Tuberc Lung Dis; 2017 May; 21(5):537-543. PubMed ID: 28399969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.